BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28303637)

  • 1. Plasma Sfrp5 levels correlate with determinants of the metabolic syndrome in Chinese adults.
    Xu Q; Wang H; Li Y; Wang J; Lai Y; Gao L; Lei L; Yang G; Liao X; Fang X; Liu H; Li L
    Diabetes Metab Res Rev; 2017 Sep; 33(6):. PubMed ID: 28303637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Sfrp5 is a signature of obesity-related metabolic disorders and is regulated by glucose and liraglutide in humans.
    Hu W; Li L; Yang M; Luo X; Ran W; Liu D; Xiong Z; Liu H; Yang G
    J Clin Endocrinol Metab; 2013 Jan; 98(1):290-8. PubMed ID: 23185036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma SFRP5 levels are decreased in Chinese subjects with obesity and type 2 diabetes and negatively correlated with parameters of insulin resistance.
    Hu Z; Deng H; Qu H
    Diabetes Res Clin Pract; 2013 Mar; 99(3):391-5. PubMed ID: 23290274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SFRP5 correlates with obesity and metabolic syndrome and increases after weight loss in children.
    Tan X; Wang X; Chu H; Liu H; Yi X; Xiao Y
    Clin Endocrinol (Oxf); 2014 Sep; 81(3):363-9. PubMed ID: 24330025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of asymptomatic target organ damage with secreted frizzled related protein 5 in the elderly: the Northern Shanghai Study.
    Teliewubai J; Bai B; Zhou Y; Lu Y; Yu S; Chi C; Li J; Blacher J; Xu Y; Zhang Y
    Clin Interv Aging; 2018; 13():389-395. PubMed ID: 29551893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance is associated with Sfrp5 in obstructive sleep apnea.
    Sun S; Zhai H; Zhu M; Wen P; He X; Wang H
    Braz J Otorhinolaryngol; 2019; 85(6):739-745. PubMed ID: 30120048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Zbed3 Levels in Subjects With and Without Metabolic Syndrome.
    Hu W; Tian B; Li X; Li L; Zhang L; Liu H; Yang G; Liu Y; Fan X
    Metab Syndr Relat Disord; 2017 Jun; 15(5):207-212. PubMed ID: 28346859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inverse associations between serum levels of secreted frizzled-related protein-5 (SFRP5) and multiple cardiometabolic risk factors: KORA F4 study.
    Carstensen-Kirberg M; Kannenberg JM; Huth C; Meisinger C; Koenig W; Heier M; Peters A; Rathmann W; Roden M; Herder C; Thorand B
    Cardiovasc Diabetol; 2017 Aug; 16(1):109. PubMed ID: 28851362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secreted Frizzled-Related Protein 5 (SFRP5) in Patients with Obstructive Sleep Apnea.
    Zhang DM; Huang R; Xiao Y; Gong FY; Zhong X; Luo JM
    Chin Med Sci J; 2017 Dec; 32(4):211-217. PubMed ID: 29301595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating SFRP5 levels are elevated in drug-naïve recently diagnosed type 2 diabetic patients as compared with prediabetic subjects and controls.
    Canivell S; Rebuffat S; Ruano EG; Kostov B; Sisó-Almirall A; Novials A; Ceriello A; Gomis R
    Diabetes Metab Res Rev; 2015 Feb; 31(2):212-9. PubMed ID: 25139699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balanced duo of anti-inflammatory SFRP5 and proinflammatory WNT5A in children.
    Prats-Puig A; Soriano-Rodríguez P; Carreras-Badosa G; Riera-Pérez E; Ros-Miquel M; Gomila-Borja A; de Zegher F; Ibáñez L; Bassols J; López-Bermejo A
    Pediatr Res; 2014 Jun; 75(6):793-7. PubMed ID: 24603290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sfrp5 correlates with insulin resistance and oxidative stress.
    Carstensen M; Herder C; Kempf K; Erlund I; Martin S; Koenig W; Sundvall J; Bidel S; Kuha S; Roden M; Tuomilehto J
    Eur J Clin Invest; 2013 Apr; 43(4):350-7. PubMed ID: 23398169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating secreted frizzled-related protein 5 (Sfrp5) and wingless-type MMTV integration site family member 5a (Wnt5a) levels in patients with type 2 diabetes mellitus.
    Lu YC; Wang CP; Hsu CC; Chiu CA; Yu TH; Hung WC; Lu LF; Chung FM; Tsai IT; Lin HC; Lee YJ
    Diabetes Metab Res Rev; 2013 Oct; 29(7):551-6. PubMed ID: 23653377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sfrp5 associates with beta-cell function in humans.
    Carstensen-Kirberg M; Hatziagelaki E; Tsiavou A; Chounta A; Nowotny P; Pacini G; Dimitriadis G; Roden M; Herder C
    Eur J Clin Invest; 2016 Jun; 46(6):535-43. PubMed ID: 27019073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between high-fasting insulin levels and metabolic syndrome in non-diabetic middle-aged and elderly populations: a community-based study in Taiwan.
    Chen YH; Lee YC; Tsao YC; Lu MC; Chuang HH; Yeh WC; Tzeng IS; Chen JY
    BMJ Open; 2018 May; 8(5):e016554. PubMed ID: 29724734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel potential biomarker for metabolic syndrome in Chinese adults: Circulating protein disulfide isomerase family A, member 4.
    Chien CY; Hung YJ; Shieh YS; Hsieh CH; Lu CH; Lin FH; Su SC; Lee CH
    PLoS One; 2017; 12(6):e0179963. PubMed ID: 28650993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of circulating WNT-signaling proteins and WNT-inhibitors in human adiposity, insulin resistance, insulin secretion, and inflammation.
    Almario RU; Karakas SE
    Horm Metab Res; 2015 Feb; 47(2):152-7. PubMed ID: 25089371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating bone morphogenetic protein-9 in relation to metabolic syndrome and insulin resistance.
    Xu X; Li X; Yang G; Li L; Hu W; Zhang L; Liu H; Zheng H; Tan M; Zhu D
    Sci Rep; 2017 Dec; 7(1):17529. PubMed ID: 29235531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating zinc-α2-glycoprotein levels are low in newly diagnosed patients with metabolic syndrome and correlate with adiponectin.
    Lei L; Li K; Li L; Fang X; Zhou T; Zhang C; Luo Y; Liu H; Li X; Zheng H; Zhang L; Yang G; Gao L
    Nutr Metab (Lond); 2017; 14():53. PubMed ID: 28814962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assesement of serum Sfrp5/Wnt-5a level and its utility in the risk stratification of treatment naïve patients with metabolic syndrome.
    Yadav SS; Hussain S; Dwivedi P; Khattri S; Sawlani KK; Usman K
    J Immunoassay Immunochem; 2023 Jan; 44(1):1-12. PubMed ID: 35880703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.